Clinical Trial Update: Phase III, Multicentre, Randomised Study of Fludarabine/Cyclophosphamide Combination With or Without Rituximab in Patients With Untreated Mantle Cell Lymphoma [Phase 2, Phase 3]

View source ↗

Summary

Phase II/III randomized study evaluating fludarabine/cyclophosphamide with or without rituximab in untreated mantle cell lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Mantle Cell Lymphoma

Drugs mentioned

• Fludarabine/Cyclophosphamide
• Rituximab (rituximab)

Snippet

Sponsor: University College, London | Conditions: Lymphoma | Phase 2, Phase 3 | Status: COMPLETED